CARBOHYDRATE COUNTING MAY BE NOT THE RIGHT WAY: A SURVEY OF CHILDREN WITH TYPE 1 DIABETES MELLITUS IN PUMP THERAPY

Session Name
HUMAN FACTOR IN THE USE OF DIABETES TECHNOLOGY
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Date
20.02.2020, Thursday
Session Time
09:30 - 15:30
Channel
E-Poster Area
Lecture Time
10:20 - 10:21
Presenter
  • Angela Zanfardino, Italy
Authors
  • Angela Zanfardino, Italy
  • Assunta S. Rollato, Italy
  • Santino Confetto, Italy
  • Veronica Testa, Italy
  • Alessia Piscopo, Italy
  • Francesca Casaburo, Italy
  • Emanuele Miraglia del giudice, Italy
  • Anna Gentile, Italy
  • Antonietta Chianese, Italy
  • Dario Iafusco, Italy

Abstract

Background and Aims

Carbohydrate counting (CHC) is a method to estimate the insulin bolus which aims is to reduce post-prandial glycemic excursion. CHC must be integrated into the nutritional education of type 1 diabetes and managed by multidisciplinary team.

In view of the growing importance of CHC in Hybrid Cloosed Loop Insulin Delivery Systems, we tried to understand if the educational effort of the caring team to train the patient to the use of CHC reaches the goal: long term use of this method.

Methods

Fifty-six children and adolescents with type 1 diabetes treated with insulin pump, and their parents, were enrolled for the study and answered the survey. They and their parents had been trained for CHC almost one year before the survey and, in post-training visits, learning was reinforced.

Results

One year after the CHC training, 6 patients (10,7%) dropped out insulin pump therapy. Twenty-three patients (41%) didn’t use CHC and 5 patients (9.5%) used it rarely. Between the “non users” 51% was not able in the counting, 14% didn’t trust of the bolus calculator, 20% thought they didn't need it, 15% considered it too complex.

Conclusions

This survey shows that CHC is not suitable for all patients. This could be a problem for Hybrid Cloosed Loop Systems that need the correct use of the bolus calculator. Such systems should minimize the patient's engagement in bolus management and so they could be used by a wider population of patients.

Hide